Sign In
Buy A
$137.40
+2.36 (+1.75%)
At Close: Jun 03, 2026
Agilent Technologies' overexposure to China headwinds prompts analyst downgrade
03:46pm, Friday, 17'th Nov 2023
Agilent Technologies (NYSE:A) has been downgraded from ‘Buy' to ‘Neutral' by UBS analysts who believe that the life sciences and diagnostics company's overexposure to regional headwinds in China,
Agilent to Present at the Evercore ISI HealthCONx Conference
11:59am, Friday, 17'th Nov 2023
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will pres
What to Note Ahead of Agilent Technologies' (A) Q4 Earnings
12:01pm, Thursday, 16'th Nov 2023
Agilent's (A) results for the fiscal fourth quarter are expected to reflect strength across the ACG amid weakness in the LSAG segment.
Agilent Technologies (A) Beats Stock Market Upswing: What Investors Need to Know
07:33pm, Wednesday, 15'th Nov 2023
In the closing of the recent trading day, Agilent Technologies (A) stood at $113.60, denoting a +1.78% change from the preceding trading day.
Agilent raises dividend by 5%
04:11pm, Wednesday, 15'th Nov 2023
Agilent Technologies Inc. A, +1.78% late Wednesday said it has increased its dividend 5% to 23.6 cents a share. The dividend will be paid on Jan. 24 to shareholders of record as of the close of busine
Agilent Technologies (A) Stock Dips While Market Gains: Key Facts
07:32pm, Wednesday, 08'th Nov 2023
Agilent Technologies (A) reachead $109.39 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.
Agilent (A) Bolsters NTD Research With SIDC Partnership
12:01pm, Tuesday, 10'th Oct 2023
Agilent (A) collaborates with Sarawak Infectious Disease Centre to provide the latter with its 6475 triple quadrupole LC/MS system, enabling rapid outbreak response for neglected tropical diseases.
Agilent Not As Agile As Hoped As Life Sciences Demand Proves To Be Less Than Invincible
04:14pm, Tuesday, 26'th Sep 2023
Demand from biopharmas for life sciences equipment has not sustained high expectations in 2023, leading to weaker growth and negative revisions for companies like Agilent. Biopharma and industrial com
Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
10:35am, Tuesday, 26'th Sep 2023
The Healthcare sector has seen a modest bid since mid-July compared to the S&P 500, with a reach for perceived safety. Agilent Technologies is a leading supplier in the Life Sciences Tools and Service
Illumina names Agilent executive as new CEO
07:46am, Tuesday, 05'th Sep 2023
Illumina Inc. ILMN, +1.96% on Tuesday announced that its board has appointed Agilent Technologies Inc. A, +0.69% senior vice president Jacob Thaysen as its new CEO, effective Sept. 25. The DNA sequenc
Agilent (A) Q3 Earnings Beat Estimates, Revenues Fall Y/Y
02:44pm, Wednesday, 16'th Aug 2023
Agilent Technologies' (A) third-quarter fiscal 2023 results reflect weakness in the LSAG segment and China market.
Agilent stock falls after lab instrument maker trims full-year outlook on China weakness
08:15am, Wednesday, 16'th Aug 2023
Agilent Technologies Inc. A shares fell 2% premarket on Wednesday after the laboratory instrument maker late Tuesday trimmed its full-year revenue and earnings outlook, citing weakness in China. The c
Agilent Technologies, Inc. (A) Q3 2023 Earnings Call Transcript
08:31pm, Tuesday, 15'th Aug 2023
Agilent Technologies, Inc. (NYSE:A ) Q3 2023 Earnings Conference Call August 15, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and CFO
Markets Remain Sold; H&R Block (HRB), Agilent (A) Beat
07:57pm, Tuesday, 15'th Aug 2023
The Dow slid -360 points in today's trading session, -1.02%, while the Nasdaq was down -157 points, -1.14%.
Agilent (A) Reports Q3 Earnings: What Key Metrics Have to Say
07:12pm, Tuesday, 15'th Aug 2023
The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended July 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates an
